CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemia

Acute myeloid leukemia (AML) relapse is considered to be related to escape from antitumor immunity. Changes in the expression of immune checkpoints, including B7 homolog (H)1 and B7-H2, have been reported to contribute to AML progression. Binding of T cell immunoglobulin and immunoreceptor tyrosine-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaito, Yuta, Hirano, Mitsuhito, Futami, Muneyoshi, Nojima, Masanori, Tamura, Hideto, Tojo, Arinobu, Imai, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721849/
https://www.ncbi.nlm.nih.gov/pubmed/34992684
http://dx.doi.org/10.3892/ol.2021.13169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721849/
https://www.ncbi.nlm.nih.gov/pubmed/34992684
http://dx.doi.org/10.3892/ol.2021.13169

Ejemplares similares